Century Therapeutics, Inc.
IPSC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850119
In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Century Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- −8 vs. Q2 2025
- Shares held
- 20.3M
- −2.31M (−10.2%) vs. Q2 2025
- Total value
- $10.1M
- −$2.52M (−19.9%) vs. Q2 2025
- New holders
- 5
- 9 more added
- Sold out
- 13
- 29 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IPSC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $387.0M |
| Q1 2026 | 72 | $315.6M |
| Q4 2025 | 47 | $25.6M |
| Q3 2025 | 57 | $10.1M |
| Q2 2025 | 65 | $12.6M |
| Q1 2025 | 70 | $14.1M |
| Q4 2024 | 72 | $36.8M |
| Q3 2024 | 67 | $67.8M |
| Q2 2024 | 61 | $102.3M |
| Q1 2024 | 67 | $96.6M |
| Q4 2023 | 63 | $58.7M |
| Q3 2023 | 55 | $36.1M |
| Q2 2023 | 64 | $61.0M |
| Q1 2023 | 64 | $69.5M |
| Q4 2022 | 65 | $107.2M |
| Q3 2022 | 54 | $208.7M |
| Q2 2022 | 56 | $182.8M |
| Q1 2022 | 52 | $278.9M |
| Q4 2021 | 50 | $335.2M |
| Q3 2021 | 49 | $496.2M |
| Q2 2021 | 36 | $490.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Century Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $0 | 0.00% | −12,196−100.0% | Reduced |
| CWM, LLC | 254 | $0 | 0.00% | −7,897−96.9% | Reduced |
| Royal Bank of Canada | 71 | $0 | 0.00% | −28−28.3% | Reduced |
| IFP Advisors, Inc | 6 | $3 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 28 | $14 | 0.00% | −427−93.8% | Reduced |
| Optiver Holding B.V. | 32 | $16 | 0.00% | +32 | New |
| SRS Capital Advisors, Inc. | 99 | $49 | 0.00% | +99 | New |
| Morgan Stanley | 118 | $59 | 0.00% | −11,222−99.0% | Reduced |
| UBS Group AG | 337 | $168 | 0.00% | −27,689−98.8% | Reduced |
| Advisory Services Network, LLC | 407 | $203 | 0.00% | +407 | New |
| Mark Sheptoff Financial Planning, LLC | 500 | $249 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 598 | $298 | 0.00% | −2,692−81.8% | Reduced |
| Nisa Investment Advisors, LLC | 883 | $440 | 0.00% | −379−30.0% | Reduced |
| Point72 (DIFC) Ltd | 1,064 | $530 | 0.00% | −685−39.2% | Reduced |
| BNP Paribas Arbitrage, SA | 1,478 | $736 | 0.00% | −2,203−59.8% | Reduced |
| SBI Securities Co., Ltd. | 1,530 | $762 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,593 | $793 | 0.00% | −1,044−39.6% | Reduced |
| Citigroup Inc | 2,210 | $1.10K | 0.00% | −13,763−86.2% | Reduced |
| Advisors Asset Management, Inc. | 8,412 | $4.19K | 0.00% | −86−1.0% | Reduced |
| AQR Capital Management LLC | 10,660 | $5.31K | 0.00% | −136,508−92.8% | Reduced |
| Jain Global LLC | 11,241 | $5.60K | 0.00% | −29,035−72.1% | Reduced |
| Tower Research Capital LLC (TRC) | 13,116 | $6.53K | 0.00% | −9,246−41.3% | Reduced |
| Quadrant Private Wealth Management, LLC | 15,286 | $7.61K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 17,501 | $8.71K | 0.00% | −50,236−74.2% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 17,861 | $8.89K | 0.00% | −19,023−51.6% | Reduced |
| HRT Financial LP | 18,113 | $9.00K | 0.00% | −92,951−83.7% | Reduced |
| Bluefin Capital Management, LLC | 24,018 | $12.0K | 0.01% | +24,018 | New |
| XTX Topco Ltd | 27,558 | $13.7K | 0.00% | +27,558 | New |
| Parametrica Management Ltd | 27,840 | $13.9K | 0.02% | 00.0% | Unchanged |
| HarbourVest Partners LLC | 29,018 | $14.5K | 0.01% | 00.0% | Unchanged |
| Marshall Wace, LLP | 54,161 | $27.1K | 0.00% | −85,546−61.2% | Reduced |
| Jane Street Group, LLC | 58,732 | $29.2K | 0.00% | −385,858−86.8% | Reduced |
| Prudential Financial Inc | 59,800 | $29.8K | 0.00% | +14,400+31.7% | Added |
| Goldman Sachs Group Inc | 60,682 | $30.2K | 0.00% | −215,296−78.0% | Reduced |
| Northern Trust Corp | 67,000 | $33.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 67,924 | $33.8K | 0.00% | −132,027−66.0% | Reduced |
| Wealth Enhancement Advisory Services, LLC | 77,853 | $43.5K | 0.00% | −3,394−4.2% | Reduced |
| Raymond James Financial Inc | 91,323 | $45.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 127,443 | $63.5K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 192,139 | $95.7K | 0.00% | −828,475−81.2% | Reduced |
| Squarepoint Ops LLC | 236,053 | $117.6K | 0.00% | +195,573+483.1% | Added |
| Citadel Advisors LLC | 360,825 | $179.7K | 0.00% | +174,291+93.4% | Added |
| Geode Capital Management, LLC | 445,309 | $221.8K | 0.00% | +65,032+17.1% | Added |
| Superstring Capital Management LP | 462,963 | $230.6K | 0.23% | 00.0% | Unchanged |
| BlackRock, Inc. | 599,656 | $298.6K | 0.00% | −325,027−35.2% | Reduced |
| Gsa Capital Partners LLP | 603,479 | $301.0K | 0.03% | +136,873+29.3% | Added |
| Acadian Asset Management LLC | 719,808 | $357.0K | 0.00% | +412,711+134.4% | Added |
| Millennium Management LLC | 743,781 | $370.4K | 0.00% | −68,432−8.4% | Reduced |
| Two Sigma Advisers, LP | 857,600 | $427.1K | 0.00% | +490,500+133.6% | Added |
| Tang Capital Management LLC | 900,000 | $448.2K | 0.02% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 911,446 | $453.9K | 0.00% | +338,902+59.2% | Added |
| Syncona Portfolio Ltd | 1,213,056 | $604.1K | 2.18% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,228,190 | $611.6K | 0.05% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 1,704,232 | $848.7K | 0.21% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,103,869 | $1.05M | 0.00% | −6,213−0.3% | Reduced |
| Renaissance Technologies LLC | 2,586,900 | $1.29M | 0.00% | +564,400+27.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,538,609 | $1.76M | 0.12% | −1,871,752−34.6% | Reduced |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −163,377−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −89,975−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −62,947−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −26,700−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −22,419−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −17,582−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,767−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −10,176−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −6,274−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,978−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −861−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −119−100.0% | Sold out |